🔗 Share this article

An underground market for unlicensed slimming drugs is being driven by social media fitness personalities and vendors on communication apps, based on recent findings.

Investigational Drug Acquiring Traction Via Social Media

The experimental drug, which remains in clinical trials, is being promoted by online personalities for its alleged fat-burning properties. Viewers are urged to contact these profiles directly for source information, while also obtaining promotional offers.

Active Trade on Social Networks

Separately, a flourishing trade exists on messaging services, where groups with numerous of participants share comparison photos, injection guides and assertions of next-day UK delivery. Vendors market the substance there before redirecting buyers to WhatsApp for transactions.

Understanding The Experimental Drug

Retatrutide is an experimental injection created by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies suggest it could help individuals reduce up to a quarter of their total weight. Referred to as the “triple G”, the drug is being promoted digitally as the successor to Ozempic.

Healthcare Experts Voice Concerns

However, physicians and pharmacists have warned that the distribution of what remains an unlicensed drug in the UK is worrisome and could result in users administering products of unknown origin.

Some experts stated the demand for the experimental drug could be connected to the increasing price of licensed weight loss products such as Mounjaro.

Regulatory Status and Implementation

Selling the unapproved drug on TikTok or Telegram is prohibited in the United Kingdom, as it is an unlicensed drug that must not be marketed or supplied for human use under the Human Medicines Regulations 2012.

Some content creators try to circumvent the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted substance, but advertising and distribution can still breach pharmaceutical, advertising, and consumer laws, risking penalties, prosecution or prison.

Platform Reaction and Material Removal

Based on TikTok, the platform has removed violative content and banned associated keywords and search suggestions. The organization said it was committed to keeping the platform secure and investing in enhancing enforcement strategies.

Digital Trading Operations

Research also discovered groups with up to 9,000 members marketing the experimental drug using Telegram's integrated discovery tool, which operates like a public directory. Typing “retatrutide” instantly displays channels with numerous of members, populated with photos of weight loss, glowing reviews and detailed instructions for preparing or injecting at home.

After moments of entering one group, a vendor posted WhatsApp details, where most transactions take place. The seller sent an guidebook and guaranteed delivery within 48 hours. When questioned whether the product was genuine, one vendor said: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. None asked about weight, medical conditions or past usage.

Product Details and Costs

Within these communities, messages display black plastic parcels with postal service labels, stating to include new batches. One communication stated: “It took eight of us to load them this morning.”

Buyers can select between powder vials, prepared at home with sterile water, or pre-filled injectors usually sold at £160 for 20mg. When questioned how much time a pen should last, sellers give contradictory responses varying between a several days to “depends on your body”.

Platform Moderation and Safety Measures

A spokesperson for the messaging service stated it regularly moderated harmful content on its service including content that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“People are injecting materials they cannot confirm. Although the science behind retatrutide is valid, these online products may not include what they advertise,” stated a pharmacy expert, the director of pharmacy at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor linked the surge in interest to recent cost increases for approved slimming medications such as Mounjaro. “With prices rising, patients are using online platforms. But counterfeit injections are extremely risky. You cannot know what’s contained or whether the conditions they were made in was sterile,” she explained.

Her team has previously seen patients harmed by personal administration from unverified sources. “We understand the frustration, but buying from Telegram or WhatsApp is gambling with your well-being,” said the doctor. “These substances could be contaminated or improperly measured.”

Producer Position

A spokesperson from the pharmaceutical company stated the substance was in third stage clinical trials and had not been evaluated or approved by any regulatory agency anywhere in the world. “Consequently at this time no one can market [it] for personal consumption,” they explained, noting that any product “falsely representing itself as a company experimental product not yet approved … may expose patients to potentially serious health risks”.